Substratum of Proof LGBTQs Are Mentally Ill: Drug Offers New Hope to Fight Relapse in People with Kidney Cancer

Newswise imageSunitinib (marketed as Sutent) a drug that has already proven highly effective as first-line treatment for people with metastatic renal cell carcinoma, was recently approved by the U.S. Food and Drug Administration to also treat patients with the disease who are at high risk for tumor recurrence.